12:00 AM
 | 
Sep 13, 1999
 |  BC Week In Review  |  Company News  |  Deals

Orion, Roberts Pharmaceutical deal

Roberts acquired exclusive U.S. marketing rights to Orion's Fareston toremifene oral nonsteroidal antiestrogen to treat advanced breast cancer. Orion will...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >